Testing effectiveness (Phase 2)Study completedNCT02047461
What this trial is testing
Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Who this might be right for
Molybdenum Cofactor Deficiency, Type A
Origin Biosciences 8